SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-17-001772
Filing Date
2017-07-14
Accepted
2017-07-14 16:54:04
Documents
78
Period of Report
2017-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K peregrine_10k-043017.htm 10-K 1058161
2 COMPREHENSIVE ARTICLES AND CERTIFICATES OF INCORPORATION peregrine_ex0301.htm EX-3.1 442586
3 SUBSIDIARIES peregrine_ex21.htm EX-21 1689
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM peregrine_ex2301.htm EX-23.1 2271
5 CERTIFICATION peregrine_ex3101.htm EX-31.1 8655
6 CERTIFICATION peregrine_ex3102.htm EX-31.2 8448
7 CERTIFICATION peregrine_ex32.htm EX-32 5819
14 GRAPHIC image_001.jpg GRAPHIC 49596
  Complete submission text file 0001683168-17-001772.txt   5710714

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE pphm-20170430.xml EX-101.INS 1086536
9 XBRL SCHEMA FILE pphm-20170430.xsd EX-101.SCH 43193
10 XBRL CALCULATION FILE pphm-20170430_cal.xml EX-101.CAL 70519
11 XBRL DEFINITION FILE pphm-20170430_def.xml EX-101.DEF 200074
12 XBRL LABEL FILE pphm-20170430_lab.xml EX-101.LAB 329130
13 XBRL PRESENTATION FILE pphm-20170430_pre.xml EX-101.PRE 302106
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-32839 | Film No.: 17965955
SIC: 2834 Pharmaceutical Preparations